Express Scripts Holding Co

Find Ratings Reports
ESRX : NASDAQ : Health Care
$60.19 up 0.04 | 0.067%
Today's Range: 59.8201 - 60.33
Avg. Daily Volume: 5284700.0
05/24/17 - 10:54 AM ET

Financial Analysis


EXPRESS SCRIPTS HOLDING CO's gross profit margin for the first quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. Even though sales decreased, the net income has increased. EXPRESS SCRIPTS HOLDING CO has weak liquidity. Currently, the Quick Ratio is 0.59 which shows a lack of ability to cover short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.

During the same period, stockholders' equity ("net worth") has increased by 7.28% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)24654.924791.8
EBITDA ($mil)1444.81431.8
EBIT ($mil)1054.6940.8
Net Income ($mil)546.3526.1


Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)3163.81771.1
Total Assets ($mil)51056.051107.6
Total Debt ($mil)15527.516591.3
Equity ($mil)15922.614841.1


Profitability Q1 FY17 Q1 FY16
Gross Profit Margin7.737.57
EBITDA Margin5.865.77
Operating Margin4.283.79
Sales Turnover1.961.99
Return on Assets6.75.01
Return on Equity21.517.25
Debt Q1 FY17 Q1 FY16
Current Ratio0.710.6
Debt/Capital0.490.53
Interest Expense145.7131.9
Interest Coverage7.247.13


Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)593.53632.54
Div / share0.00.0
EPS0.90.81
Book value / share26.8323.46
Institutional Own % n/a n/a
Avg Daily Volume5121758.04124032.0

Valuation


HOLD. EXPRESS SCRIPTS HOLDING CO's P/E ratio indicates a significant discount compared to an average of 22.94 for the Health Care Providers & Services industry and a significant discount compared to the S&P 500 average of 25.02. For additional comparison, its price-to-book ratio of 2.21 indicates a discount versus the S&P 500 average of 3.00 and a discount versus the industry average of 3.31. The price-to-sales ratio is well below both the S&P 500 average and the industry average, indicating a discount. Upon assessment of these and other key valuation criteria, EXPRESS SCRIPTS HOLDING CO proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ESRX 10.74 Peers 22.94   ESRX 6.87 Peers 11.23

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

ESRX is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ESRX is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ESRX 7.71 Peers 16.12   ESRX 0.36 Peers 1.27

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

ESRX is trading at a significant discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ESRX trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ESRX 2.21 Peers 3.31   ESRX 45.64 Peers 17.26

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ESRX is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

ESRX is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ESRX 0.35 Peers 0.86   ESRX -1.47 Peers 10.61

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ESRX is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ESRX significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades